Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis
NCT06039241
·
clinicaltrials.gov ↗
RECRUITING
Status
900
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Sponsor
Sanofi